Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to tame Africa's blood pressure crisis

NCT ID NCT06986590

Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program to help 800 adults in Africa get their high blood pressure under control. It combines patient education, provider training, and health system improvements. The goal is to lower blood pressure and reduce the risk of heart disease, stroke, and kidney problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 -70 years. * Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis. * Hypertension treatment naive or on monotherapy. * Receives primary care at one of the participating sites. * Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba. * Owns a smartphone (Android or iOS). Exclusion Criteria: * Age \<18 years or \>70 years. * Severely elevated BP (≥180/110mmHg). * Diagnosis of stroke, coronary artery disease, or kidney disease. * Diagnosis of end-stage renal disease (ESRD) treated with dialysis. * Serious medical condition which either limits life expectancy or requires active management (e.g., cancer). * Cognitive impairment or other conditions preventing study participation * Pregnant or currently nursing a child * Unwilling to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for High blood pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

High blood pressure Hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Akoko North East

    NOT_YET_RECRUITING

    Ondo, Ondo State, Nigeria

  • Akoko North West

    NOT_YET_RECRUITING

    Ondo, Ondo State, Nigeria

  • Akoko South East

    NOT_YET_RECRUITING

    Ondo, Ondo State, Nigeria

  • Akoko South West

    NOT_YET_RECRUITING

    Ondo, Ondo State, Nigeria

  • Akure South Hospital

    RECRUITING

    Akure, Ondo State, Nigeria

  • Berekum Holy Family Hospital

    NOT_YET_RECRUITING

    Berekum, Bono, Ghana

  • Dominase SDA Hospital

    NOT_YET_RECRUITING

    Bekwai, Ashanti Region, Ghana

  • Ho Municipal Hospital

    NOT_YET_RECRUITING

    Ho, Volta Region, Ghana

  • Johns Hopkins University

    ACTIVE_NOT_RECRUITING

    Baltimore, Maryland, 21205, United States

  • Kumasi South Hospital

    NOT_YET_RECRUITING

    Kumasi, Ashanti Region, Ghana

  • Manhyia Government Hospital

    RECRUITING

    Kumasi, Ashanti Region, Ghana

  • Northern Regional Hospital

    RECRUITING

    Tamale, Northern Region, Ghana

  • Owo General Hospital

    NOT_YET_RECRUITING

    Owo, Ondo State, Nigeria

  • South Tongu District Hospital

    NOT_YET_RECRUITING

    Sogakope, Volta Region, Ghana

  • St. John of God Catholic Hospital

    RECRUITING

    Duayaw Nkwanta, Bono, Ghana

  • Tafo Government Hospital

    NOT_YET_RECRUITING

    Tafo, Ashanti Region, Ghana

  • Tamale Teaching Hospital

    NOT_YET_RECRUITING

    Tamale, Northern Region, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.